Stephen ZOU
Partner, LIU, SHEN & ASSOCIATES
Yuan ZHANG
Patent Attorney, LIU, SHEN & ASSOCIATES
Mingde XIA
Chairman and CEO
Innolake Biopharm
Jialin SUN
CEO, GTJA Investment Group
Dan LIU
Partner of Venture and Growth Capital, CDH Investments
Fred Mao
Frost & Sullivan Partner & Managing Director
Ya MA
Counsel, Head of Greater China Healthcare, Freshfields Bruckhaus Deringer LLP
Hongshan SHEN
Director and Senior Partner, DeHeng Law Offices(Shanghai)
Kevin REN
Founding Partner & CEO, Das Capital
Pei ZHOU
Partner, Xincheng Fund
Weibin WANG
Senior Partner, Beshining
Fei JIANG
Managing Director, Hongtai Aplus
Feng TAO
Founding Partner, BioTrack Capital
Liang ZHANG
Managing Director, IN Capital
Jeffrey SUN
Partner, Orrick Herrington
& Sutcliffe

Mark XU
Chairman and CEO, Xynomic Pharmaceuticals (Nanjing) Co., Ltd.
Harm-Jan Borgeld
Vice President, Head of Roche Pharma Partnering Asia
Andy FU
Co-Founder, Chief Business Officer of ONCUSP
Min WU
Chief Business Officer,
Therorna Inc
Min WU
Chief Business Officer,
Therorna Inc
Han DAI
CBO and Head of Investment, BIOINNOVATOR (A Viva Biotech Division)
Ning LI
CEO, Shanghai Junshi Biosciences
Hua JIANG
Director of External Innovation and Partnerships, Abbott Medicine
Bin LI
Venture Partner, Lilly Asia Ventures
Aaron ZHOU
Partner, Han Kun Law Offices
Wei WU
Principal, Venture Investments, Johnson&Johnson Innovation-JJDC
Ying Niu
China Search and Evaluation Lead, Worldwide Business Development, Pfizer
Yan SONG
Founder & CEO, Link Health Group
Jolee LI
Partner, Lang Sheng Investment Group
Luna JI
Director of Businesses and Development & Licensing ,  Asia Pacific Search & Evaluation, MSD
Katherine LU
Partner, LYZZ Capital
Kathy HE
Chief Business Officerand General Manager (China), Kira Pharmaceuticals
David Yu
Audit & Assurance National Leader, Deloitte China Life Sciences & Health Care Industry; Eastern Region Offering Services Leader, Deloitte China Capital Market Services Group
Hanmei XU
Founder and Chairman, Nanjing Anji Biotechnology
Jay Dong
Co-Founder & CEO, HplanetBio Partner, KP Healthcare Partners
Yongbin GE
Senior Partner, Zhong Lun Law Firm
Ying Li
Counsel, Han Kun Law Offices
Jianwen HUANG
Leading Partner of Healthcare Group, King & Wood Mallesons
Viva He
Director of Business Development & Venture Investment, AstraZeneca China
Lei HUANG
Investment Director
Fosun Health Capital
Qicong HU
Managing Director and Partner, Boston Consulting Group
Feng BIAN
Executive Director, Integrative Sciences, China R&D, Bristol Myers Squibb
26 December: pre session training
Formal meeting on December 27-28